Largest clinical trial in Africa for people with mild COVID-19 to test new treatment
NAIROBI / KINSHASA / GENEVA – 27 APRIL 2021 – The ANTICOV clinical trial, conducted in 13 African countries, has started the recruitment of participants to test a new drug combination, nitazoxanide + ciclesonide, to treat people with mild-to-moderate COVID-19 before their cases become severe. The ANTICOV study is being carried out by a consortium…
Details